| 注册
首页|期刊导航|中国当代医药|骨髓联合外周血单倍体相合造血干细胞移植治疗急性白血病的临床效果

骨髓联合外周血单倍体相合造血干细胞移植治疗急性白血病的临床效果

徐小丽

中国当代医药2018,Vol.25Issue(16):59-62,4.
中国当代医药2018,Vol.25Issue(16):59-62,4.

骨髓联合外周血单倍体相合造血干细胞移植治疗急性白血病的临床效果

Clinical effect of bone marrow combined with peripheral blood haploidentical hematopoietic stem cell transplantation in the treatment of acute leukemia

徐小丽1

作者信息

  • 1. 广东省佛山市第一人民医院血液内科,广东 佛山 528000
  • 折叠

摘要

Abstract

Objective To explore the clinical effect of bone marrow combined with peripheral blood haploid-matched hematopoietic stem cell transplantation in the treatment of acute leukemia.Methods Fifty -three patients with acute leukemia who underwent allogeneic hematopoietic stem cell transplantation in our hospital from January 2007 to January 2016 were retrospectively analyzed.According to different transplantation methods,they were divided into experimental group(22 cases)and control group(31cases).Patients in experimental group were treated with bone marrow combined with peripheral blood haploid hematopoietic stem cell transplantation,patients in control group were treated with bone marrow stem cell transplantation,and peripheral blood stem cells in the experiment were mobilized by G-CSF.The recovery of blood cells,incidence of acute graft-versus-host disease (aGVHD),transplantation-related mortality,2 years recurrence rate and survival rate and adverse reaction rate were compared between the two groups.Results The survival rate of patients in the experimental group was higher than that in the control group,while the recurrence rate and incidence rate of aGVHD were lower than that in the control group,the difference was statistically significant (P<0.05).The blood routine indexes of patients in the experimental group after transplantation and follow-up were higher than those in the control group,and the difference was statistically significant (P<0.05).The incidence of adverse events in the experimental group was lower than that in the control group,and the difference was statistically significant (P<0.05).Conclusion Bone marrow combined with peripheral blood haploidentical hematopoietic stem cell transplantation is of great significance in the treatment of acute leukemia,and can reduce the recurrence rate and incidence of aGVHD on the basis of improving the quality of life. It is worth applying and popularizing.

关键词

骨髓/造血干细胞移植/急性白血病

Key words

Bone marrow/Hematopoietic stem cell transplantation/Acute leukemia

分类

医药卫生

引用本文复制引用

徐小丽..骨髓联合外周血单倍体相合造血干细胞移植治疗急性白血病的临床效果[J].中国当代医药,2018,25(16):59-62,4.

中国当代医药

1674-4721

访问量0
|
下载量0
段落导航相关论文